Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study
- Author:
Hong Jae JEON
1
;
Hong Jin BAE
;
Young Rok HAM
;
Dae Eun CHOI
;
Ki Ryang NA
;
Moon Sang AHN
;
Kang Wook LEE
Author Information
- Publication Type:Original Article
- Keywords: Comorbidity; End-stage renal disease; Kidney transplantation; Waiting lists
- MeSH: Blood Group Antigens; Cause of Death; Chungcheongnam-do; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Glomerulonephritis; Humans; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Kidney; Korea; Mortality; Peritoneal Dialysis; Prevalence; Renal Replacement Therapy; Tissue Donors; Waiting Lists
- From:Kidney Research and Clinical Practice 2019;38(1):116-123
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: Kidney transplantation is an effective renal replacement therapy for patients with end-stage renal disease (ESRD). In this study, we assessed the impact of the baseline characteristics and comorbidities of ESRD patients on the probability of deceased donor kidney transplantation (DDKT) and evaluated the morbidity and mortality during the time spent waiting. METHODS: The study population consisted of 544 ESRD patients on the waiting list for DDKT at Chungnam National University Hospital in South Korea between February 2000 and October 2015. The patients were observed from the date of transplantation list registration to the date of transplantation. Baseline characteristics and comorbidities were investigated together with new-onset comorbidities that occurred during the waiting time. RESULTS: Diabetes mellitus (39.0%), hypertension (25.2%), and glomerulonephritis (21.3%) were the three most common causes of ESRD in this study, and coronary artery disease (9.4%) was the most common comorbidity. The 115 patients (19.3%) who underwent DDKT had a mean waiting time of 1,711 days (768–2,654 days or 4.68 years [2.10–7.27]). Blood groups other than type O, peritoneal dialysis, and nondiabetic ESRD were significantly associated with a higher likelihood of DDKT. Infection was the leading cause of death and the most common comorbidity that arose during the waiting time. Patients who experienced cardiovascular events during the waiting time showed a lower transplant rate compared with those who did not. CONCLUSION: The prevalence of comorbidities was high in renal transplantation candidates. During the often-long waiting time, new comorbidities may occur, with long-term sequelae limiting access to kidney transplantation or resulting in death.
